Literature DB >> 3549254

Direct effects of glucose on proinsulin synthesis and processing during desensitization.

S Nagamatsu, J L Bolaffi, G M Grodsky.   

Abstract

Prolonged exposure of isolated islets to glucose (11 mM) results in desensitization of insulin secretion. In this study, both glucose-regulated proinsulin biosynthesis and its processing during glucose-induced desensitization were examined at critical periods during 24 h. Although insulin secretion declined at 24 h to one third the 3 h maximum rate, the total rate of proinsulin biosynthesis, assessed by [3H]leucine incorporation, was unchanged at 0, 3, and 24 h of glucose (11 mM) exposure. Total insulin recovery measured by immunoreactive insulin in islets and media after 24 h was approximately 172% of the initial islet content. After correction for insulin degradation, and since proinsulin biosynthesis was unchanged, the synthesis rate was calculated to be a constant 3.5 +/- 1.1%/h of the initial islet content. Results suggest that desensitization may occur at the release mechanism rather than at a step in glucose metabolism common for the stimulation of synthesis and secretion. In contrast, the conversion rate of proinsulin to insulin progressively increased with prolonged prior glucose exposure, the major increase occurring by 3 h of glucose preincubation. Low glucose (2 mM), when used during the 3-h prelabeling period, did not affect the conversion rate. Furthermore, cycloheximide added during the 3-h preexposure to glucose (11 mM) completely prevented glucose-induced activation of the conversion process. These results indicate that the conversion rate of proinsulin to insulin is a glucose-regulated process requiring synthesis of a pool of either converting enzyme(s) or other regulating protein before initiation of proinsulin synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549254     DOI: 10.1210/endo-120-4-1225

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Regulation of insulin preRNA splicing by glucose.

Authors:  J Wang; L Shen; H Najafi; J Kolberg; F M Matschinsky; M Urdea; M German
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

2.  Model of synthesis and release of insulin from rat islet beta-cells and the effect of pretreatment with tolbutamide.

Authors:  H D Landahl; G Gold; G M Grodsky
Journal:  Bull Math Biol       Date:  1987       Impact factor: 1.758

3.  A fluorescent timer reporter enables sorting of insulin secretory granules by age.

Authors:  Belinda Yau; Lori Hays; Cassandra Liang; D Ross Laybutt; Helen E Thomas; Jenny E Gunton; Lindy Williams; Wayne J Hawthorne; Peter Thorn; Christopher J Rhodes; Melkam A Kebede
Journal:  J Biol Chem       Date:  2020-04-27       Impact factor: 5.157

4.  The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones.

Authors:  Carrie R Sowers; Rong Wang; Rebecca A Bourne; Barbara C McGrath; Jingjie Hu; Sarah C Bevilacqua; James C Paton; Adrienne W Paton; Sophie Collardeau-Frachon; Marc Nicolino; Douglas R Cavener
Journal:  J Biol Chem       Date:  2018-02-14       Impact factor: 5.157

5.  eIF4G1 and carboxypeptidase E axis dysregulation in O-GlcNAc transferase-deficient pancreatic β-cells contributes to hyperproinsulinemia in mice.

Authors:  Seokwon Jo; Amber Lockridge; Emilyn U Alejandro
Journal:  J Biol Chem       Date:  2019-07-12       Impact factor: 5.157

6.  The intracellular handling of insulin-related peptides in isolated pancreatic islets. Evidence for differential rates of degradation of insulin and C-peptide.

Authors:  C J Rhodes; P A Halban
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

7.  Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway.

Authors:  C J Rhodes; P A Halban
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.